Tofacitinib Citrate Topical Gel 3.2% FDA BA Bridging Study
Clinical trial NCT04468425 · COMPLETED
Trial details
- NCT number
- NCT04468425
- Sponsor
- TWi Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-14
- Primary completion
- 2020-12-21
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.